期刊文献+

HBME-1在恶性上皮性间皮瘤的表达及其意义

EXPRESSION AND SIGNIFICANCE OF HBME-1 IN MALIGNATBNT EPITHELIAL MESOTHELIOMA
下载PDF
导出
摘要 目的 通过研究HBME 1在恶性上皮性间皮瘤 (MEM )的表达及其与DNA含量的关系 ,探讨HBME 1在MEM与转移性卵巢腺癌 (OA)和转移性结直肠腺癌 (CA)的鉴别诊断中的意义。方法 采用免疫组化SP法染色 ,观察MEM、OA和CA组织标本中HBME 1的表达 ;同时利用图象分析仪对MEM的细胞DNA含量进行定量分析。结果 HBME 1的表达在MEM与CA两组间的差异有显著性 (P <0 0 1) ,在MEM与OA两组间的差异无显著性 (P <0 0 5 ) ,但着色方式不同 ;在MEM中 ,HBME 1表达阳性组与阴性组之间的DNA含量差异无显著性 (P <0 0 5 )。结论 HBME 1的表达与否与MEM的DNA含量无关 ,HBME 1可作为MEM与CA鉴别的阳性标记物的参考指标 ,在MEM与OA的鉴别中也有一定参考价值。 ? Objective To study the relationship between the expression of HBME-1 and the DNA content in malignant epithelial mesothelioma (MEM), in order to investigate the role of HBME-1 in distinguishing MEM from metastatic ovarian adenocarcinoma (OA) and colorectal adenocarcinoma (CA). Method Immunohistochemical SP method was used to detect the expression of HBME-1 in paraffin-embedded tissues from 18 MEM、20 OA and 20 CA cases. Image analysis was used to measure the cell DNA content of the 18 MEM cases. Result There was a significant difference in the expression of HBME-1 between MEM and OA groups(P<0.01), but not between MEM and OA groups (P>0.05). There was no significant difference in the cell DNA content between the HBME-1 positive and negative MEM groups (P>0.05). Conclusion The expression of HBME-1 does not correlate with the cell DNA content in MEM, and HBME-1 could be used as a positive marker in distinguishing MEM from CA. In consideration of the characteristic staining pattern of HBME-1 in MEM, it may serve as an index to discriminate MEM from OA. 〔
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2003年第2期196-200,共5页 Chinese Journal of Histochemistry and Cytochemistry
关键词 恶性间皮瘤 转移性腺癌 免疫组化 HBME-I DNA含量 上皮性间皮瘤 Malignant mesothelioma Metastatic adenocarcinoma Immunohistochemistry HBME-1 DNA content
  • 相关文献

参考文献14

二级参考文献18

  • 1梁英杰,凌启波.一种快速高敏感的免疫组织化学染色法—LSAB法[J].中华病理学杂志,1993,22(6):369-369. 被引量:71
  • 2王川,张祥福,杨发端,卢辉山,殷凤峙.nm23基因产物/NDPK在大肠癌中的表达及其临床意义[J].中华病理学杂志,1995,24(6):356-358. 被引量:31
  • 3陈艺华,董敬朋,李春德,陆药丹,张盛.人乳腺癌c-erbB2基因扩增及过度表达的研究[J].中华肿瘤杂志,1995,17(1):16-19. 被引量:23
  • 4Somerville. JE, Clarke. L, Biggart JD, et al. c-erbB-2 overexpression and histological type of in situ and invasive breast cancer. J Clin Pathol,1992,45:16.
  • 5Barnes. DM, O'Reilly, SN, Camplejohn RS, et al. The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer. Br J Cancer, 1991,63:4-449.
  • 6Fernando C, Expression of c-erbB-2 protein and DNA ploid in breast carcinogenesis. Arch Pathol Lab Med, 1995,119:815.
  • 7Borg A, Linell F. HER-2/neu amplification and comedo type breast carcinoma. Lancet, 1989,?:1268.
  • 8Van de Vijver MJ, Peterse JL. Neu-protein overexpression in breast cancer, Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage I breast cancer.New Engl J Med, 1988,319:1239.
  • 9Joel Lundy, Allan Schuss, Doris Stanick. Expression of neu protein, epidermal growth factor receptor and tranforming growth factor alpha in breast cancer. Am J Pathol, 1991,138.
  • 10Nathalie Quenel. The prognostic value of c-erbB-2 inprimary breast carcinomas:A study on 942 cases. BCRT,1995:35:283.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部